|
V0633
|
GW2580 (SC203877)
|
870483-87-7 |
GW2580 (also known as SC-203877)is a novel, potent, selective, and orally bioavailable c-Fms kinaseCSF-1R inhibitor with potential antineoplastic activity. |
|
V5140
|
PLX-5622
|
1303420-67-8 |
PLX5622 is a novel and highly selective CNS-penetrant CSF1R inhibitor, that has the potential to be used for extended and specific microglial elimination, preceding and during pathology development. |
|
V15481
|
Sulfatinib (HMPL-012)
|
1308672-74-3 |
Sulfatinib, formerly known as surufatinib, is an orally bioavailable, small molecule inhibitor of vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3, and the fibroblast growth factor receptor type 1 (FGFR1), with potential antineoplastic and anti-angiogenic activities. |
|
V0634
|
Sotuletinib (BLZ945)
|
953769-46-5 |
Sotuletinib (formerly BLZ945; BLZ-945) is a novel, potent, selective, orally bioactive,and brain-penetrantCSF-1R (colony stimulating factor 1 receptor) inhibitor with potential antitumor activity. |